The Gross Margin of Y-mAbs Therapeutics Inc (YMAB) is 82.89%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 82.89% |
2023-12-31 | 86.60% |
2022-12-31 | 88.56% |
2021-12-31 | 93.38% |